GPER1 and ovarian carcinoma: Further proof of concept demonstrating GPER-specific gene transcription was developed through additional experiments using the GPER-selective agonist, G1, and a c-fos reporter plasmid in ER-positive, GPER-positive human BG-1 ovarian carcinoma [48].